Dislipidemia y virus de inmunodeficiencia adquirida/sida

Castelo Elías-Calles, Lizet; González Calero, Teresa Margarita.
Rev. cuba. endocrinol ; 21(2): 202-222, Mayo-ago. 2010.
Artigo em Espanhol | LILACS, CUMED | ID: lil-584444

Documentos relacionados

  1. Atherosclerosis - A matter of unresolved inflammation.
  2. Lipid metabolism in asthma: Immune regulation and potential therapeutic target.
  3. Pathways involved in the resolution of inflammatory joint disease.
  4. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.
  5. Biologic therapy for dyslipidemia.
  6. Lipid Abnormalities and Inflammation in HIV Inflection.
  7. Significant Gap Between Guidelines and Practice in the Management of LDL Cholesterol: Insight From the Survey of the Korean Society of Myocardial Infarction.
  8. Medications for Dyslipidemia.
  9. Canadian dyslipidemia guidelines for family doctors.
  10. Population pharmacokinetic and pharmacokinetic-pharmacodynamic modeling of bempedoic acid and low-density lipoprotein cholesterol in healthy subjects and patients with dyslipidemia.